Undurti Narasimha Das

22PUBLICATIONS
10CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipidsOptical technologyNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Mar 02, 2026
Lipoxin A4 activates Nrf2 expression and mitigates hyperglycaemia-induced impairment of myogenesis and rescues damage to mitochondria.

Akash Mitra, Deepika Bhat K, Joel Rimson Pinto

|Feb 23, 2026
Arachidonic Acid and Lipoxin A4 Protect Pancreatic β-Cells and Improve Hyperglycemia Induced by Bleomycin.

Sailaja Polavarapu, Poorani Rhenghachar, Undurti N Das

|Nov 10, 2025
Is Sepsis an Essential Fatty Acids Deficiency State?

Undurti N Das

|Sep 15, 2025
Arachidonic Acid Protects Skeletal Muscle Against Hyperglycaemia-Induced Muscle Atrophy by Modulating Myogenesis and Regulating KLF15 Expression in C57Bl/6 Mice.

Akash Mitra, Debajit Chaudhury, Akhila Balakrishna Rai

|Feb 26, 2025
Lipoxin A4 (LXA4) as a Potential Drug for Diabetic Retinopathy.

Undurti N Das

|Jun 27, 2024
The Dysregulation of Essential Fatty Acid (EFA) Metabolism May Be a Factor in the Pathogenesis of Sepsis.

Undurti N Das

Pageof 4

Frequent Collaborators

2 joint publications

Akash Mitra

2 joint publications

Bipasha Bose

2 joint publications

Sudheer Shenoy P

1 joint publications

Sailaja Polavarapu